122455-35-0

Basic information

• Product Name: 2-fluoro-6-nitrophenyl trifluoromethanesulfonate
• Synonyms: 2-fluoro-6-nitrophenyl trifluoromethanesulfonate
• CAS NO: 122455-35-0
• Molecular Weight: 289.164
• Mol File: 122455-35-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-fluoro-6-nitrophenyl trifluoromethanesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-fluoro-6-nitrophenyl trifluoromethanesulfonate(122455-35-0)
• EPA Substance Registry System: 2-fluoro-6-nitrophenyl trifluoromethanesulfonate(122455-35-0)

Safety Data

• Hazardous Substances Data: 122455-35-0(Hazardous Substances Data)

Upstream product

• 358-23-6 trifluoromethylsulfonic anhydride 
• 1526-17-6 2-fluoro-6-nitrophenol 
• 421-83-0 trifluoromethane sulfonyl chloride 

Downstream Products

• 1072930-78-9 [5-(7-fluoro-1-propyl-1H-benzoimidazol-2-yl)-pyridin-2-yl]-(4-methoxy-phenyl)-amine 
• 1072928-96-1 3-fluoro-N-2-propyl-benzene-1,2-diamine 
• 1072928-97-2 (2-fluoro-6-nitro-phenyl)-propyl-amine 
• 122455-36-1 1-Fluoro-3-nitroiodobenzene 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12C

Provided are heterocyclic compounds as inhibitors of the KRAS G12C and uses thereof. Specifically, provided are the compounds of any of formula I to XI or stereoisomers, enantiomers, atropoisomerics or pharmaceutically acceptable salts thereof. Definition of each group in the formula can be found in the specification for details.

NICOTINIC ACID DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5

The present invention relates to novel benzimidazole derivatives, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them, wherein the compounds have the Formula (I): in which the substitutents are as defined in claim 1 and and salts, solvates, hydrates and N- oxides thereof.

Substituted-8-alkenyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acids

Indole derivatives characterized by having a 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid nucleus bearing substituents in position 1-, 5-, 6-, 7- and 8- are disclosed. The derivatives are useful anti-inflammatory and/or analgesic agents. Methods for their preparation and use are also disclosed.